SCHEMBL25065503

SCHEMBL25065503

Cc1cc2ccnnc2cc1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
MAPT P10636 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
G6PD P11413 1/20 0.40
CYP2C9 P11712 1/20 0.40
PKM P14618 1/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
CCR6 P51684 1/20 0.40
HIF1A Q16665 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GAA P10253 2/20 0.36
STAT3 P40763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28340678 0.84 EGFR (0.39) KDM4EALDH1A1HPGDMAPTCYP1A2
SCHEMBL8404464 0.84 NQO2 (0.43) KDM4EALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL24868665 0.77 LMNA (0.39) HPGDCYP1A2CYP3A4G6PDCYP2C9
SCHEMBL25092244 0.77 ESR1 (0.36) KDM4EALDH1A1HPGDMAPTALOX15
SCHEMBL24253573 0.77 CGAS (0.30) KDM4EALDH1A1HPGDGAASTAT3
SCHEMBL17885790 0.77 ALDH1A1 (0.47) KDM4EALDH1A1HPGDMAPTCYP1A2
SCHEMBL21591899 0.74 TERT (0.50) KDM4EALDH1A1HPGDMAPTCYP3A4
SCHEMBL5542743 0.73 ALDH1A1 (0.53) KDM4EALDH1A1HPGDMAPTCYP1A2
SCHEMBL24874255 0.73 KDM4E (0.48) KDM4EALDH1A1HPGDMAPTCYP1A2
SCHEMBL24253569 0.73 LMNA (0.39) KDM4EALDH1A1HPGDCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230054781-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230054781-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SF3B5 KDM4E 2544/4885ALDH1A1 3964/4885HPGD 3316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.